Patients with IDH1 mutated glioma were reported to be younger than patients with wild-type IDH1 gene (Yan et al., 2009, 2012; Molenaar et al., 2014; Qi et al., 2014; Ohno et al., 2016). The gene discussed is IDH1; the disease is central nervous system cancer.